Company Filing History:
Years Active: 2015-2025
Title: The Innovative Mind of Patricia Culp
Introduction
Patricia Culp, an accomplished inventor based in Oakland, CA, has made significant contributions to the field of biotherapeutics. With 13 patents to her name, Culp has developed groundbreaking technologies aimed at advancing medical treatments and therapies.
Latest Patents
Among Patricia's latest patents are the "Anti-SIRPα antibodies and methods of use thereof," which disclose compositions including monoclonal antibodies that specifically bind to SIRPA polypeptides. This innovation holds potential for preventing or treating individuals in need. Another significant patent is the "Anti-Siglec-5 antibodies and methods of use thereof," focusing on monoclonal and humanized antibodies that bind to Siglec-5 proteins, offering similar therapeutic applications.
Career Highlights
Patricia has worked with renowned companies like Alector LLC and AbbVie Biotherapeutics Inc., where she applied her expertise in antibody development. Her career is marked by a commitment to advancing the field of immunotherapy and addressing urgent health challenges through innovative solutions.
Collaborations
Over the years, Patricia has collaborated with notable professionals in her field, including Arnon Rosenthal and Helen Lam. These partnerships have fostered a collaborative spirit that often leads to innovative breakthroughs in medical research and product development.
Conclusion
Patricia Culp exemplifies the spirit of innovation in the biomedical field. Her dedication to her work and the development of patents that address significant medical needs showcases her status as a leading inventor. As the landscape of biotherapeutics continues to evolve, Patricia's contributions will undoubtedly play a crucial role in shaping the future of healthcare.